Company intelligence / Profile preview

ZuriMED

Schlieren, Zurich, Switzerland

Ownership: Private
Employees: ~15
Development stage: Other

Overview

ZuriMED is a Swiss medical technology company specializing in innovative solutions for orthopedic surgery, particularly ligament and tendon reconstruction. The company's flagship technology, the Surgical Fiberlock, is a functionalized suture-based scaffold designed to enhance the biological healing of torn ligaments like the ACL. By combining high-strength materials with a structure that promotes tissue ingrowth, ZuriMED aims to improve surgical outcomes and accelerate patient recovery. The company is a spin-off from the University of Zurich and ETH Zurich, leveraging advanced biomechanical research to address unmet needs in sports medicine.

Therapeutic areas: OtherRheumatology
Modalities: Device
Industry: Surgical Medical Devices

Beyond the preview

Go deeper on ZuriMED.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on ZuriMED.

Explore the full profile